A drug once intended to treat diabetes, Halicin, is showing new promise as a potent weapon against multidrug-resistant (MDR) ...

BiomX has dosed the first subject in the randomised Phase IIb trial of the company’s fixed multi-phage therapy, BX004, to ...

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

Pseudomonas aeruginosa is a notorious opportunistic pathogen, with its virulence intricately linked to the expression of specific lectins such as LecA and LecB. These carbohydrate‐binding ...

From your phone to your toothbrush, invisible armies of bacteria are lurking on the everyday objects you touch the most. Here ...

Antimicrobial resistance (AMR) is a critical global health threat, with ESKAPE pathogens — Enterococcus faecium, ...

Most of these microbes are harmless – some even helpful – but under the right conditions, a few can make you seriously ill ...

An international research team led by the Helmholtz Center for Infection Research (HZI) has discovered a new strategy used by the human pathogen Pseudomonas aeruginosa to adapt to its host. In the ...

Numerous factors can predispose someone to swimmer’s ear. They include a narrow ear canal, and skin diseases such as eczema or psoriasis. In addition, individuals wearing ear plugs, ear buds or ...

First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting ...